Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression

doi:10.1084/jem.176.5.1319

This Article

Full Text (PDF, 908K)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Dancescu, M.

Articles by Sarfati, M.

Search for Related Content

PubMed

PubMed Citation

Articles by Dancescu, M.

Articles by Sarfati, M.

Pubmed/NCBI databases

Substance via MeSH

Social Bookmarking

What's this?

ARTICLES

Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression

M Dancescu, M Rubio-Trujillo, G Biron, D Bron, G Delespesse and M Sarfati
University of Montreal, Notre-Dame Hospital Research Center, Canada.

B chronic lymphocytic leukemia (B-CLL) is characterized by the accumulation of slow-dividing and long-lived monoclonal B cells arrested at the intermediate stage of their differentiation. We previously showed that interleukin 4 (IL-4) not only inhibits but also prevents the proliferation of B-CLL cells. We report here that IL-4 protects the B-CLL cells from death by apoptosis (programmed cell death [PCD]). IL-4 inhibits spontaneous and hydrocortisone (HC)-induced PCD of highly purified B cells from 12 unselected CLL patients, as shown by sustained cell viability and lack of DNA fragmentation. IL-1, -2, -3, - 5, -6, -7, tumor necrosis factor alpha, and transforming growth factor beta have no protective effect. The in vitro rescue from apoptosis by IL-4 is reflected by an increased expression of Bcl-2 protein, a proto- oncogene directly involved in the prolongation of cell survival in vivo and in vitro. Hence, IL-4-treated B-CLL cells express significantly more Bcl-2 than unstimulated, HC-treated, or fresh B-CLL cells. Furthermore, subcutaneous injection of IL-4 into one CLL patient enhances Bcl-2 protein expression in the leukemic B cells. These data may suggest that IL-4 prevents apoptosis of B-CLL cells using a Bcl-2- dependent pathway. Given our recent observations that fresh T cells from B-CLL patients express IL-4 mRNA, we propose that IL-4 has an essential role in the pathogenesis of CLL disease, by preventing both the death and the proliferation of the malignant B cells.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Heller, N. M., Qi, X., Junttila, I. S., Shirey, K. A., Vogel, S. N., Paul, W. E., Keegan, A. D. (2008). Type I IL-4Rs Selectively Activate IRS-2 to Induce Target Gene Expression in Macrophages. Sci Signal 1: ra17-ra17 [Abstract] [Full Text]
Hewamana, S., Lin, T. T., Jenkins, C., Burnett, A. K., Jordan, C. T., Fegan, C., Brennan, P., Rowntree, C., Pepper, C. (2008). The Novel Nuclear Factor-{kappa}B Inhibitor LC-1 Is Equipotent in Poor Prognostic Subsets of Chronic Lymphocytic Leukemia and Shows Strong Synergy with Fludarabine. Clin. Cancer Res. 14: 8102-8111 [Abstract] [Full Text]
Li, Z., Jiang, J., Wang, Z., Zhang, J., Xiao, M., Wang, C., Lu, Y., Qin, Z. (2008). Endogenous Interleukin-4 Promotes Tumor Development by Increasing Tumor Cell Resistance to Apoptosis. Cancer Res. 68: 8687-8694 [Abstract] [Full Text]
Hewamana, S., Alghazal, S., Lin, T. T., Clement, M., Jenkins, C., Guzman, M. L., Jordan, C. T., Neelakantan, S., Crooks, P. A., Burnett, A. K., Pratt, G., Fegan, C., Rowntree, C., Brennan, P., Pepper, C. (2008). The NF-{kappa}B subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target. Blood 111: 4681-4689 [Abstract] [Full Text]
Landi, A., Babiuk, L. A., van Drunen Littel-van den Hurk, S. (2007). High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer. J. Leukoc. Biol. 82: 849-860 [Abstract] [Full Text]
Park, H. H., Kim, M., Lee, B.-H., Lim, J., Kim, Y., Lee, E. J., Min, W. S., Kang, C. S., Kim, W. I., Shim, S. I., Han, K. (2006). Intracellular IL-4, IL-10, and IFN-{gamma} Levels of Leukemic Cells and Bone Marrow T Cells in Acute Leukemia.. Annals of Clinical & Laboratory Science 36: 7-15 [Abstract] [Full Text]
Tinhofer, I., Rubenzer, G., Holler, C., Hofstaetter, E., Stoecher, M., Egle, A., Steurer, M., Greil, R. (2006). Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia. Blood 108: 2950-2956 [Abstract] [Full Text]
Rubenstein, J. L., Fridlyand, J., Shen, A., Aldape, K., Ginzinger, D., Batchelor, T., Treseler, P., Berger, M., McDermott, M., Prados, M., Karch, J., Okada, C., Hyun, W., Parikh, S., Haqq, C., Shuman, M. (2006). Gene expression and angiotropism in primary CNS lymphoma. Blood 107: 3716-3723 [Abstract] [Full Text]
Buhl, A. M., Jurlander, J., Jorgensen, F. S., Ottesen, A. M., Cowland, J. B., Gjerdrum, L. M., Hansen, B. V., Leffers, H. (2006). Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia. Blood 107: 2904-2911 [Abstract] [Full Text]
Todaro, M., Zerilli, M., Ricci-Vitiani, L., Bini, M., Perez Alea, M., Maria Florena, A., Miceli, L., Condorelli, G., Bonventre, S., Di Gesu, G., De Maria, R., Stassi, G. (2006). Autocrine Production of Interleukin-4 and Interleukin-10 Is Required for Survival and Growth of Thyroid Cancer Cells. Cancer Res. 66: 1491-1499 [Abstract] [Full Text]
Anichini, A., Mortarini, R., Romagnoli, L., Baldassari, P., Cabras, A., Carlo-Stella, C., Gianni, A. M., Di Nicola, M. (2006). Skewed T-cell differentiation in patients with indolent non-Hodgkin lymphoma reversed by ex vivo T-cell culture with {gamma}c cytokines. Blood 107: 602-609 [Abstract] [Full Text]
Battle, T. E., Arbiser, J., Frank, D. A. (2005). The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 106: 690-697 [Abstract] [Full Text]
Zhu, X., Hart, R., Chang, M. S., Kim, J.-W., Lee, S. Y., Cao, Y. A., Mock, D., Ke, E., Saunders, B., Alexander, A., Grossoehme, J., Lin, K.-M., Yan, Z., Hsueh, R., Lee, J., Scheuermann, R. H., Fruman, D. A., Seaman, W., Subramaniam, S., Sternweis, P., Simon, M. I., Choi, S. (2004). Analysis of the Major Patterns of B Cell Gene Expression Changes in Response to Short-Term Stimulation with 33 Single Ligands. J. Immunol. 173: 7141-7149 [Abstract] [Full Text]
Conticello, C., Pedini, F., Zeuner, A., Patti, M., Zerilli, M., Stassi, G., Messina, A., Peschle, C., De Maria, R. (2004). IL-4 Protects Tumor Cells from Anti-CD95 and Chemotherapeutic Agents via Up-Regulation of Antiapoptotic Proteins. J. Immunol. 172: 5467-5477 [Abstract] [Full Text]
Decker, T., Oelsner, M., Kreitman, R. J., Salvatore, G., Wang, Q.-c., Pastan, I., Peschel, C., Licht, T. (2004). Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins. Blood 103: 2718-2726 [Abstract] [Full Text]
Stassi, G., Todaro, M., Zerilli, M., Ricci-Vitiani, L., Di Liberto, D., Patti, M., Florena, A., Di Gaudio, F., Di Gesu, G., De Maria, R. (2003). Thyroid Cancer Resistance to Chemotherapeutic Drugs via Autocrine Production of Interleukin-4 and Interleukin-10. Cancer Res. 63: 6784-6790 [Abstract] [Full Text]
Jones, D. T., Ganeshaguru, K., Anderson, R. J., Jackson, T. R., Bruckdorfer, K. R., Low, S. Y., Palmqvist, L., Prentice, H. G., Hoffbrand, A. V., Mehta, A. B., Wickremasinghe, R. G. (2003). Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. Blood 101: 3174-3180 [Abstract] [Full Text]
Sarfati, M., Mateo, V., Baudet, S., Rubio, M., Fernandez, C., Davi, F., Binet, J.-L., Delic, J., Merle-Beral, H. (2003). Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells. Blood 101: 265-269 [Abstract] [Full Text]
Barragan, M., Bellosillo, B., Campas, C., Colomer, D., Pons, G., Gil, J. (2002). Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells. Blood 99: 2969-2976 [Abstract] [Full Text]
Bernal, A., Pastore, R. D., Asgary, Z., Keller, S. A., Cesarman, E., Liou, H.-C., Schattner, E. J. (2001). Survival of leukemic B cells promoted by engagement of the antigen receptor. Blood 98: 3050-3057 [Abstract] [Full Text]
Moreno, A., Villar, M. L., Camara, C., Luque, R., Cespon, C., Gonzalez-Porque, P., Roy, G., Lopez-Jimenez, J., Bootello, A., Santiago, E. R. (2001). Interleukin-6 dimers produced by endothelial cells inhibit apoptosis of B-chronic lymphocytic leukemia cells. Blood 97: 242-249 [Abstract] [Full Text]
Wagner, E. F., Hanna, N., Fast, L. D., Kouttab, N., Shank, P. R., Vazquez, A., Sharma, S. (2000). Novel Diversity in IL-4-Mediated Responses in Resting Human Naive B Cells Versus Germinal Center/Memory B Cells. J. Immunol. 165: 5573-5579 [Abstract] [Full Text]
Nilsson, J., Soderberg, O., Nilsson, K., Rosen, A. (2000). Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells. Blood 95: 1420-1426 [Abstract] [Full Text]
Byrd, J. C., Shinn, C., Ravi, R., Willis, C. R., Waselenko, J. K., Flinn, I. W., Dawson, N. A., Grever, M. R. (1999). Depsipeptide (FR901228): A Novel Therapeutic Agent With Selective, In Vitro Activity Against Human B-Cell Chronic Lymphocytic Leukemia Cells. Blood 94: 1401-1408 [Abstract] [Full Text]
Wickremasinghe, R. G., Hoffbrand, A. V. (1999). Biochemical and Genetic Control of Apoptosis: Relevance to Normal Hematopoiesis and Hematological Malignancies. Blood 93: 3587-3600 [Full Text]
Caligaris-Cappio, F., Hamblin, T. J. (1999). B-Cell Chronic Lymphocytic Leukemia: A Bird of a Different Feather. JCO 17: 399-399 [Abstract] [Full Text]
LOSMAN, J., CHEN, X.P., JIANG, H., PAN, P.-Y., KASHIWADA, M., GIALLOURAKIS, C., COWAN, S., FOLTENYI, K., ROTHMAN, P. (1999). IL-4 Signaling Is Regulated through the Recruitment of Phosphatases, Kinases, and SOCS Proteins to the Receptor Complex. Cold Spring Harb Symp Quant Biol 64: 405-416 [Abstract]
Lai, Y. H., Mosmann, T. R. (1999). Mouse IL-13 Enhances Antibody Production In Vivo and Acts Directly on B Cells In Vitro to Increase Survival and Hence Antibody Production. J. Immunol. 162: 78-87 [Abstract] [Full Text]
Kaminski, A., Demaine, A., Prentice, A. (1998). Cytoplasmic Interleukin-4 (IL-4) and Surface IL-4 Receptor Expression in Patients With B-Cell Lymphocytic Leukemia. Blood 92: 2188-2189 [Full Text]
Romano, M. F., Lamberti, A., Tassone, P., Alfinito, F., Costantini, S., Chiurazzi, F., Defrance, T., Bonelli, P., Tuccillo, F., Turco, M. C., Venuta, S. (1998). Triggering of CD40 Antigen Inhibits Fludarabine-Induced Apoptosis in B Chronic Lymphocytic Leukemia Cells. Blood 92: 990-995 [Abstract] [Full Text]
Zhao, H., Dugas, N., Mathiot, C., Delmer, A., Dugas, B., Sigaux, F., Kolb, J.-P. (1998). B-Cell Chronic Lymphocytic Leukemia Cells Express a Functional Inducible Nitric Oxide Synthase Displaying Anti-Apoptotic Activity. Blood 92: 1031-1043 [Abstract] [Full Text]
Zamorano, J., Keegan, A. D. (1998). Regulation of Apoptosis by Tyrosine-Containing Domains of IL-4R{alpha}: Y497 and Y713, But Not the STAT6-Docking Tyrosines, Signal Protection from Apoptosis. J. Immunol. 161: 859-867 [Abstract] [Full Text]
Lagneaux, L., Delforge, A., Bron, D., De Bruyn, C., Stryckmans, P. (1998). Chronic Lymphocytic Leukemic B Cells But Not Normal B Cells Are Rescued From Apoptosis by Contact With Normal Bone Marrow Stromal Cells. Blood 91: 2387-2396 [Abstract] [Full Text]
Konig, A., Schwartz, G. K., Mohammad, R. M., Al-Katib, A., Gabrilove, J. L. (1997). The Novel Cyclin-Dependent Kinase Inhibitor Flavopiridol Downregulates Bcl-2 and Induces Growth Arrest and Apoptosis in Chronic B-Cell Leukemia Lines. Blood 90: 4307-4312 [Abstract] [Full Text]
Konig, A., Wrazel, L., Warrell Jr, R. P., Rivi, R., Pandolfi, P. P., Jakubowski, A., Gabrilove, J. L. (1997). Comparative Activity of Melarsoprol and Arsenic Trioxide in Chronic B-Cell Leukemia Lines. Blood 90: 562-570 [Abstract] [Full Text]
Jurlander, J., Lai, C.-F., Tan, J., Chou, C.-C., Geisler, C. H., Schriber, J., Blumenson, L. E., Narula, S. K., Baumann, H., Caligiuri, M. A. (1997). Characterization of Interleukin-10 Receptor Expression on B-Cell Chronic Lymphocytic Leukemia Cells. Blood 89: 4146-4152 [Abstract] [Full Text]
Bellosillo, B., Dalmau, M., Colomer, D., Gil, J. (1997). Involvement of CED-3/ICE Proteases in the Apoptosis of B-Chronic Lymphocytic Leukemia Cells. Blood 89: 3378-3384 [Abstract] [Full Text]
Osorio, L. M., De Santiago, A., Aguilar-SantelisesHa, M., Mellstedt, k., Jondal, M. (1997). CD6 Ligation Modulates the Bcl-2/Bax Ratio and Protects Chronic Lymphocytic Leukemia B Cells From Apoptosis Induced by Anti-IgM. Blood 89: 2833-2841 [Abstract] [Full Text]
Douglas, R. S., Capocasale, R. J., Lamb, R. J., Nowell, P. C., Moore, J. S. (1997). Chronic Lymphocytic Leukemia B Cells Are Resistant to the Apoptotic Effects of Transforming Growth Factor-beta. Blood 89: 941-947 [Abstract] [Full Text]
Thompson, C. (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462 [Abstract]